Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| General assessment of applied therapy modalities in pancreatic cancer | First diagnose to death or end of surveillance (5 years after curative resection) | |
| Quality of life in pancreatic cancer patients | EORTC QLQ c30 and PAN 26 | First diagnose to death or end of surveillance (5 years after curative resection) |
| Measure | Description | Time Frame |
|---|---|---|
| General epidemiologic assessment | Epidemiologic questionaire | First diagnose to death or end of surveillance (5 years after curative resection) |
| Assessment of tumor surveillance in pancreatic cancer patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All adult newly diagnosed patients with a PDAC could be included in the registry trial.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Thomas Seufferlein, MD | Contact | +49 731 50044501 | thomas.seufferlein@uniklinik-ulm.de |
| Name | Affiliation | Role |
|---|---|---|
| Thomas Seufferlein, MD | Ulm University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universitätsklinikum Ulm | Recruiting | Ulm | Germany |
Not provided
| ID | Term |
|---|---|
| D010190 | Pancreatic Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| First diagnose to death or end of surveillance (5 years after curative resection) |
| Evaluation of predictive and prognostic markers | First diagnose to death or end of surveillance (5 years after curative resection) |
| D004066 |
| Digestive System Diseases |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |